Avid Bioservices, Inc. (TEHP.F)
- Previous Close
6.25 - Open
6.25 - Bid 6.85 x --
- Ask 6.90 x --
- Day's Range
6.25 - 6.25 - 52 Week Range
4.12 - 16.70 - Volume
171 - Avg. Volume
9 - Market Cap (intraday)
319.741M - Beta (5Y Monthly) 1.62
- PE Ratio (TTM)
46.60 - EPS (TTM)
0.15 - Earnings Date Apr 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
28.25
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
www.avidbio.com365
Full Time Employees
April 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: TEHP.F
Performance Overview: TEHP.F
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TEHP.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TEHP.F
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.93%
Return on Assets (ttm)
-2.27%
Return on Equity (ttm)
-9.67%
Revenue (ttm)
136.74M
Net Income Avi to Common (ttm)
-17.68M
Diluted EPS (ttm)
0.15
Balance Sheet and Cash Flow
Total Cash (mrq)
30.71M
Total Debt/Equity (mrq)
108.97%
Levered Free Cash Flow (ttm)
-46.99M
Research Analysis: TEHP.F
Company Insights: TEHP.F
TEHP.F does not have Company Insights